Allstate Corporation’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.55M	Buy	27,526 +17,765	+182%	+$1.04M	0.02%	615
2025 Q4	$580K	Buy	9,761 +3,402	+53%	+$185K	0.01%	586
2025 Q3	$344K	Buy	+6,359	New	+$364K	0.01%	572
2025 Q2	–	Sell	-8,352	Closed	-$590K	–	222
2025 Q1	$590K	Buy	8,352 +2,758	+49%	+$186K	0.02%	473
2024 Q4	$368K	Buy	+5,594	New	+$375K	0.01%	551
2023 Q1	–	Sell	-5,978	Closed	-$619K	–	243
2022 Q4	$619K	Buy	5,978 +155	+3%	+$14.6K	0.02%	457
2022 Q3	$494K	Hold	5,823	–	–	0.01%	496
2022 Q2	$483K	Sell	5,823 -4,274	-42%	-$340K	0.01%	508
2022 Q1	$778K	Buy	+10,097	New	+$845K	0.02%	447
2020 Q3	–	Sell	-6,245	Closed	-$770K	–	669
2020 Q2	$770K	Buy	6,245 +1,982	+46%	+$197K	0.03%	317
2020 Q1	$360K	Buy	+4,263	New	+$367K	0.01%	441
2019 Q4	–	Sell	-32,536	Closed	-$2.19M	–	617
2019 Q3	$2.19M	Buy	32,536 +4,727	+17%	+$364K	0.04%	275
2019 Q2	$2.38M	Buy	+27,809	New	+$2.38M	0.04%	250
2017 Q3	–	Sell	-16,358	Closed	-$1.49M	–	61
2017 Q2	$1.49M	Sell	16,358 -11,188	-41%	-$1.02M	0.08%	129
2017 Q1	$2.42M	Sell	27,546 -11,900	-30%	-$1.06M	0.15%	105
2016 Q4	$3.27M	Buy	39,446 +23,121	+142%	+$1.99M	0.2%	143
2016 Q3	$1.51M	Buy	+16,325	New	+$1.54M	0.11%	131